Journal Watch · Nature Communications · 2026

Internalized components of membrane attack complexes disrupt proteostasis and acquire alarmin-like properties.

Our data show that the C9 component of MACs forms intracellular aggregates with alarmin-like properties.

Song G, Ma Z, Fan M et al.Nature Communications3 min readPharma relevance 65/100

DOI: 10.1038/s41467-026-75696-0PMID: 42469261Study type: preclinical (animal / model) study

TL;DR

Our data show that the C9 component of MACs forms intracellular aggregates with alarmin-like properties.

Key findings

  • We detect C9 aggregates in vivo, and we show that a ZFYVE21-RNF34 signaling axis is required for C9 aggrephagy and NF-κB -dependent EC activation in three separate mouse models.
  • Mice with conditional loss of ZFYVE21 in ECs show reduced aggregraphy, resulting in attenuated systemic inflammation and reduced tissue injury following skin transplantation.
  • Our data show that the C9 component of MACs forms intracellular aggregates with alarmin-like properties.

What they did

We identify NUMBL as a Rab35 effector that directly binds surface-bound C9 to promote C9 internalization and entry into the endolysosomal pathway. Within acidified endolysosomes, C9 forms insoluble aggregates that are targeted for degradative aggrephagy in a process that activates NF-κB. For C9 aggrephagy to occur, ZFYVE21, a Rab5 effector, complexes with RNF34 to bridge C9 aggregates to LC3B+ aggresome membranes.

Full abstract (original)

Background: Immune effects of membrane attack complexes (MAC) have been widely attributed to their abilities to cause cell death. Here, we show that the MAC component, C9, forms non-cytolytic aggregates with pro-inflammatory effects. Intracellular aggregates of C9 are detected within inflamed tissues of patients in association with endothelial cell (EC) activation but not increased cell death.

What they did: We identify NUMBL as a Rab35 effector that directly binds surface-bound C9 to promote C9 internalization and entry into the endolysosomal pathway. Within acidified endolysosomes, C9 forms insoluble aggregates that are targeted for degradative aggrephagy in a process that activates NF-κB. For C9 aggrephagy to occur, ZFYVE21, a Rab5 effector, complexes with RNF34 to bridge C9 aggregates to LC3B+ aggresome membranes.

Results & conclusions: We detect C9 aggregates in vivo, and we show that a ZFYVE21-RNF34 signaling axis is required for C9 aggrephagy and NF-κB -dependent EC activation in three separate mouse models. Mice with conditional loss of ZFYVE21 in ECs show reduced aggregraphy, resulting in attenuated systemic inflammation and reduced tissue injury following skin transplantation. Our data show that the C9 component of MACs forms intracellular aggregates with alarmin-like properties.

Abstract © the authors / Nature Communications (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1038/s41467-026-75696-0 · PubMed 42469261.

Why it matters for pharma & biotech

  • Relevant to General & Medicine teams tracking Nature Communications for new targets, mechanisms and biomarkers.
  • Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The work is preclinical. Results in animal or cell models frequently do not translate directly to human efficacy or safety.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Nature Communications study find?

Our data show that the C9 component of MACs forms intracellular aggregates with alarmin-like properties.

What type of study is this?

It is a preclinical (animal / model) study, published in Nature Communications in 2026. We identify NUMBL as a Rab35 effector that directly binds surface-bound C9 to promote C9 internalization and entry into the endolysosomal pathway.

Where can I read the original paper?

The original is at the publisher via DOI 10.1038/s41467-026-75696-0. PubMed ID: 42469261. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Song G, Ma Z, Fan M et al.. Internalized components of membrane attack complexes disrupt proteostasis and acquire alarmin-like properties.. Nature Communications (2026). DOI: 10.1038/s41467-026-75696-0.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/internalized-components-of-membrane-attack-complexes-disrupt-proteostasi-756960/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides